Risk Of Systemic Lupus Erythematosus In Patients With Idiopathic Background: idiopathic thrombocytopenic purpura (itp) may play a role in early stage systemic lupus erythematosus (sle). the incidence of sle in patients with itp and the potential relationship between them is still unclear. this study was performed to provide epidemiological evidence regarding the relationship between itp and sle occurrence. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: population based cohort study ann rheum dis . 2020 jul 22;annrheumdis 2020 218128. doi: 10.1136 annrheumdis 2020 218128.
Risk Of Systemic Lupus Erythematosus In Patients With Idiopathic Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopaenic purpura. risk of systemic lupus erythematosus in patients with idiopathic thrombocytopaenic purpura. ann rheum dis. 2022 may;81 (5):e81. doi: 10.1136 annrheumdis 2020 217659. epub 2020 apr 24. We read the published article by zhu et al 1 with great interest. in this population based retrospective cohort study, the authors demonstrated that the patients with idiopathic thrombocytopaenic purpura (itp) had a 26 times higher risk of new onset systemic lupus erythematosus (sle) compared with the control population. however, some concerns do exist and should be addressed. first. We read with great interest the article by zhu et al .1 it was based on a national study regarding the association between idiopathic thrombocytopenic purpura (itp) and the subsequent development of systemic lupus erythematosus (sle), both representing clinically and genetically heterogeneous autoimmune diseases. according to the data presented in this study, the authors demonstrated that the. The risk of systemic lupus erythematosus (sle) was higher for patients with idiopathic thrombocytopenic purpura (itp) in a report published in the annals of rheumatic diseases. patient data for this retrospective cohort analysis were examined from the national health insurance research database in taiwan.
Systemic Lupus Erythematosus Sle Risk Factors Treatment Options And We read with great interest the article by zhu et al .1 it was based on a national study regarding the association between idiopathic thrombocytopenic purpura (itp) and the subsequent development of systemic lupus erythematosus (sle), both representing clinically and genetically heterogeneous autoimmune diseases. according to the data presented in this study, the authors demonstrated that the. The risk of systemic lupus erythematosus (sle) was higher for patients with idiopathic thrombocytopenic purpura (itp) in a report published in the annals of rheumatic diseases. patient data for this retrospective cohort analysis were examined from the national health insurance research database in taiwan. Background idiopathic thrombocytopenic purpura (itp) may play a role in early stage systemic lupus erythematosus (sle). the incidence of sle in patients with itp and the potential relationship. Systemic lupus erythematosus (sle) is a common autoimmune disease with a wide range of manifestations. 1 multiple genetic and environmental factors are implicated in the disease occurrence and progression, resulting in difference in severity and outcome of the disease. 2 skin is one of the most commonly affected organs. in fact, some of the.
Systemic Lupus Erythematosus Sle Diagram Quizlet Background idiopathic thrombocytopenic purpura (itp) may play a role in early stage systemic lupus erythematosus (sle). the incidence of sle in patients with itp and the potential relationship. Systemic lupus erythematosus (sle) is a common autoimmune disease with a wide range of manifestations. 1 multiple genetic and environmental factors are implicated in the disease occurrence and progression, resulting in difference in severity and outcome of the disease. 2 skin is one of the most commonly affected organs. in fact, some of the.
Frontiers Endothelial Dysfunction In Systemic Lupus Erythematosus And
Comments are closed.